Sign In
Buy ASRT
$23.47
+0.0200 (+0.0853%)
At Close: Jun 03, 2026
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04:05pm, Thursday, 06'th Jun 2024
LAKE FOREST, Ill., June 06, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities o
Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024
08:30am, Wednesday, 05'th Jun 2024
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities o
Assertio to Participate in Benchmark Healthcare Conference on May 21-22
09:15am, Friday, 17'th May 2024
LAKE FOREST, Ill., May 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities of
Letter Expresses Several Significant Concerns and Recommends That Further Investigation is Warranted Urges Assertio Stockholders to Vote Against All Directors at Upcoming Annual Meeting in Order to Ei
Assertio to Participate in AGP Healthcare Conference on May 21
09:16am, Thursday, 16'th May 2024
LAKE FOREST, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities of
Urges Assertio Stockholders to Vote Against All Directors at Upcoming Annual Meeting in Order to Either Pressure Current Board to Accept New Stockholder-Recommended Directors or Force Resignations of
Assertio to Present at the Citizens JMP Life Sciences Conference in New York City
03:12pm, Friday, 10'th May 2024
LAKE FOREST, Ill., May 10, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities of
Assertio Holdings, Inc. (ASRT) Q1 2024 Earnings Call Transcript
07:07pm, Monday, 06'th May 2024
Assertio Holdings, Inc. (NASDAQ:ASRT ) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ET Company Participants Matthew Kreps - Darrow Associates, IR Heather Mason - Interim CEO Ajay Patel - CFO P
Assertio Reports First Quarter 2024 Financial Results
04:01pm, Monday, 06'th May 2024
First Quarter Net Product Sales of $31.9 Million
Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024
08:00am, Thursday, 25'th Apr 2024
LAKE FOREST, Ill., April 25, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities
Assertio to Present at LD Micro Invitational Conference in New York City
09:00am, Monday, 01'st Apr 2024
LAKE FOREST, Ill., April 01, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities
Assertio Holdings Inc. (ASRT) Q4 2023 Earnings Call Transcript
06:02pm, Monday, 11'th Mar 2024
Assertio Holdings Inc. (NASDAQ:ASRT ) Q4 2023 Earnings Conference Call March 11, 2024 4:30 PM ET Company Participants Matthew Kreps - Darrow Associates, IR Heather Mason - Interim CEO Ajay Patel - CFO
Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
04:01pm, Monday, 11'th Mar 2024
Fourth Quarter Net Product Sales $32.5 Million, Cash Flow from Operations of $5.7 Million
NEW YORK, NY / ACCESSWIRE / March 5, 2024 / If you suffered a loss on your Assertio Holdings, Inc. (NASDAQ:ASRT) investment and want to learn about a potential recovery under the federal securities la
The Gross Law Firm Notifies Assertio Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ASRT
05:45am, Tuesday, 05'th Mar 2024
NEW YORK , March 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Assertio Holdings, Inc.. Shareholders who purchased shares of ASRT during the class period l
